Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
复制标题
DOI：
10.1016/s1386-6532(01)00172-x
复制
发表时间：
2001-08-01
影响因子：
8.8
通讯作者：
Hakama, M
中科院分区：
文献类型：
--
作者：
Lehtinen, M;Luukkaala, T;Hakama, M
Background: Human papillomavirus (HPV) is the major cause of cervical neoplasia but estimates of the population attributable fraction (PAR%), of HPV vary. PAR% has not been derived from longitudinal studies although assessment of HPV exposure prior to the neoplasia diagnosis should increase validity of such estimates. Aims: Systematic review and meta-analysis of longitudinal studies on HPV associated relative risk (RR) for and PAR% of HPV16 in cervical neoplasia. Methods: Pertinent data from longitudinal studies was made available through Medline and substituted by various hand searches. HPV associated weighted mean RR, with 95% confidence interval (CI) of cervical neoplasia, and the PAR% of HPV16 in cervical carcinoma were estimated both for unselected and low HPV prevalence populations. Results: HPV associated RR of cervical carcinoma in PCR-based studies was 17 (95% CI 8.2-33). HPV16 associated RRs in seroepidemiological studies were 3.3 (95% CI 2.2-4.9) for the unselected population, HPV16 seroprevalence 11.0%, and 12.5 (95% CI 5.5-29) for a population with low HPV16 seroprevalence of 5.3%. Corresponding PAR% estimates of HPV16 were 27 and 44%, respectively. Conclusion: Protective vaccination against HPV16 infection would prevent up to 44% of cervical carcinoma. (C) 2001 Elsevier Science B.V. All rights reserved.
